Overall Assessment: The stock has experienced significant volatility over the past six months, reaching a high near $47.06 in early January 2026 before a sharp decline. The 6-month price change is slightly positive at 0.98%, but the stock is down 13.38% over the last three months and 14.27% year-to-date, indicating a recent bearish trend.

Short-term Performance: Over the past month, the stock declined by 0.53%, which was a relative outperformance compared to the S&P 500's 5.25% drop. However, the three-month performance shows a more pronounced decline of 13.38%, significantly underperforming the broader market's 4.63% loss.

Current Position: The current price of $39.23 sits well below the 52-week high of $47.27 but remains significantly above the 52-week low of $29.52. This places the stock in the middle of its annual range, having retreated from its recent peak.

Revenue & Profitability: Revenue for Q4 2025 was $3.94 billion, showing a year-over-year decline of 2.4%. Quarterly net income was $327 million, a significant improvement from $108 million in Q4 2024. The net margin for the latest quarter was 8.3%, up from 2.7% a year ago, indicating improved profitability despite lower revenue.

Financial Health: The debt-to-equity ratio stands at 1.40, indicating a leveraged balance sheet typical for financial institutions. Operating cash flow for Q4 2025 was $652 million, but free cash flow over the trailing twelve months is negative at -$534 million, primarily due to significant capital expenditures and investment activities.

Operational Efficiency: Return on Equity (ROE) is 5.50%, which is modest. The current ratio is 0.90, suggesting potential liquidity constraints in covering short-term obligations with current assets. The trailing twelve-month free cash flow is negative, highlighting cash usage for growth or investment.